IPOPLUS

₹6,663.5

▼ -49 -0.73%

17 Jun 2026

NSE Listed · Pharmaceuticals

Divis Laboratories Ltd. (DIVISLAB)

Volume: 15,821Avg Vol 1W: 39,439Avg Vol 1M: 2,02,57052W Range:₹5,636.5₹7,071.5
NSE BSE
₹6,663.5▼ 0.73%
Key Ratios
Updated 3h ago
Market Cap₹1,78,218 Cr
Current Price₹6,663.5
Previous Close₹6,712.5
High / Low (52w)₹7,071.5 / ₹5,636.5
Volume15,821
Avg Vol (1W)39,439
Avg Vol (1M)2,02,570
Stock P/E—
Book Value₹632.49
Dividend Yield0.45%
ROE15.32%
ROA12.82%
Revenue (TTM)—
Revenue Growth19.31%
Profit Margin24.32%
Total Debt₹0 Cr
Shares Outstanding27 Cr
Face Value₹2
EPS (TTM)₹28.31
P/B10.61
Debt / Equity0
50 DMA₹6,718.91
200 DMA₹6,338.49
Day change-0.73%
Price Chart
₹6,663.5▲ 0.92% · 1Y
₹6922₹581019.3L
2025-10-20
2026-06-16

20-day avg volume: 2.2L shares

Pros
  • Healthy return on equity of 15.3%.
  • Company is almost debt-free.
  • Revenue grew 19% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹2,831 Cr₹2,604 Cr₹2,715 Cr₹2,410 Cr₹2,585 Cr₹2,319 Cr₹2,338 Cr₹2,118 Cr₹2,303 Cr₹1,855 Cr₹1,909 Cr₹1,778 Cr₹1,951 Cr₹1,708 Cr₹1,855 Cr₹2,255 Cr₹2,518 Cr₹2,493 Cr₹1,988 Cr₹1,961 Cr₹1,788 Cr₹1,701 Cr₹1,749 Cr₹1,730 Cr₹1,390 Cr
EBITDA₹969 Cr₹860 Cr₹920 Cr₹736 Cr₹865 Cr₹726 Cr₹723 Cr₹604 Cr₹715 Cr₹489 Cr₹470 Cr₹492 Cr₹466 Cr₹435 Cr₹615 Cr₹852 Cr₹1,076 Cr₹1,034 Cr₹760 Cr₹815 Cr₹670 Cr₹642 Cr₹694 Cr₹661 Cr₹471 Cr
Net Profit₹751 Cr₹583 Cr₹689 Cr₹545 Cr₹662 Cr₹589 Cr₹510 Cr₹430 Cr₹538 Cr₹358 Cr₹348 Cr₹356 Cr₹321 Cr₹306 Cr₹493 Cr₹702 Cr₹895 Cr₹902 Cr₹606 Cr₹557 Cr₹502 Cr₹471 Cr₹520 Cr₹492 Cr₹388 Cr
EPS28.3121.9825.9720.4924.9322.219.216.220.2513.513.1113.4112.0911.5618.626.4433.733.9922.8420.9918.9117.7319.5718.5414.62
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹9,712 Cr₹8,184 Cr₹8,112 Cr₹9,074 Cr₹7,032 Cr₹5,584 Cr
EBITDA₹2,918 Cr₹2,166 Cr₹2,369 Cr₹3,684 Cr₹2,667 Cr₹1,826 Cr
Net Profit₹2,191 Cr₹1,600 Cr₹1,823 Cr₹2,960 Cr₹1,984 Cr₹1,377 Cr
EPS82.5360.2768.69111.5274.7551.85
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹16,932 Cr₹15,470 Cr₹14,439 Cr₹13,375 Cr₹10,774 Cr₹8,536 Cr
Total Liabilities₹1,963 Cr₹1,899 Cr₹1,672 Cr₹1,647 Cr₹1,479 Cr₹1,226 Cr
Equity₹14,969 Cr₹13,571 Cr₹12,767 Cr₹11,728 Cr₹9,295 Cr₹7,310 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹2,477 Cr₹1,637 Cr₹2,932 Cr₹2,553 Cr₹2,591 Cr₹1,661 Cr
Investing₹-804 Cr₹-269 Cr₹-2,708 Cr₹-2,195 Cr₹75 Cr₹-83 Cr
Financing₹-799 Cr₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr
Free Cash Flow₹2,477 Cr₹1,637 Cr₹2,932 Cr₹2,553 Cr₹2,591 Cr₹1,661 Cr
Shareholding
Promoter 51.88% Institutions 39.51% Public 8.6%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search